Quantum Genomics Corp. Appoints Fabrice Balavoine Head Of Research

JERSEY CITY, N.J--(BUSINESS WIRE)--Quantum Genomics Corp (QGC), a global biotechnology company seeking to transform the discoveries and developments of academic research into breakthrough treatments for human disease, announced today that it has appointed Fabrice Balavoine as Head of Research.

Back to news